Your browser doesn't support javascript.
loading
Second-line therapy with nivolumab plus ipilimumab for older patients with oesophageal squamous cell cancer (RAMONA): a multicentre, open-label phase 2 trial.
Ebert, Matthias P; Meindl-Beinker, Nadja M; Gutting, Tobias; Maenz, Martin; Betge, Johannes; Schulte, Nadine; Zhan, Tianzuo; Weidner, Philip; Burgermeister, Elke; Hofheinz, Ralf; Vogel, Arndt; Angermeier, Stefan; Bolling, Claus; de Wit, Maike; Jakobs, Ralf; Karthaus, Meinolf; Stocker, Gertraud; Thuss-Patience, Peter; Leidig, Tobias; Gaiser, Timo; Kather, Jakob N; Haertel, Nicolai.
Afiliação
  • Ebert MP; Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Mannheim Cancer Center, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Mannheim Institute for Innate Immunoscience, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany;
  • Meindl-Beinker NM; Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Mannheim Cancer Center, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Gutting T; Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Mannheim Cancer Center, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Maenz M; AIO Studien, Berlin, Germany.
  • Betge J; Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Mannheim Cancer Center, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, Mannheim, Germany; Junior Clinical Cooper
  • Schulte N; Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Mannheim Cancer Center, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Zhan T; Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Mannheim Cancer Center, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Weidner P; Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Mannheim Cancer Center, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Burgermeister E; Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Mannheim Cancer Center, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Hofheinz R; Interdisciplinary Tumor Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Vogel A; Department of Gastroenterology, Hepatology und Endocrinology, Hannover Medical School, Hannover, Germany.
  • Angermeier S; Department of Internal Medicine I, Klinikum Ludwigsburg, Ludwigsburg, Germany.
  • Bolling C; Department of Internal Medicine, Agaplesion Markus Krankenhaus Frankfurt, Diakonie Kliniken, Frankfurt, Germany.
  • de Wit M; Department of Internal Medicine, Hematology, Oncology and Palliative Medicine, Vivantes Klinikum Neukölln, Berlin, Germany.
  • Jakobs R; Department of Medicine C, Klinikum der Stadt Ludwigshafen, Ludwigshafen, Germany.
  • Karthaus M; Department of Hematology, Oncology and Palliative Care, Klinikum Neuperlach, Munich, Germany.
  • Stocker G; University Cancer Center, University Medicine Leipzig, Leipzig, Germany.
  • Thuss-Patience P; Department of Hematology, Medical Oncology and Tumor Immunology, Charité Universitätsmedizin, Berlin, Germany.
  • Leidig T; CROLLL, Nuremberg, Germany.
  • Gaiser T; Institute of Pathology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Kather JN; Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
  • Haertel N; Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Mannheim Cancer Center, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Lancet Healthy Longev ; 3(6): e417-e427, 2022 06.
Article em En | MEDLINE | ID: mdl-36098320
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas do Esôfago Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male Idioma: En Revista: Lancet Healthy Longev Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas do Esôfago Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male Idioma: En Revista: Lancet Healthy Longev Ano de publicação: 2022 Tipo de documento: Article